Table 1. Correlations between BCYRN1 expression and clinicopathological characteristics in GC.
Characteristics | n | High expression | Low expression | P |
---|---|---|---|---|
Gender | ||||
Female | 47 | 26 (55.3) | 21 (44.7) | 0.324 |
Male | 80 | 37 (46.3) | 43 (53.8) | |
Age (y) | ||||
<50 | 52 | 25 (48.1) | 27 (51.9) | 0.774 |
≥50 | 75 | 38 (50.7) | 37 (49.3) | |
Clinical stage | ||||
I-II | 58 | 18 (31.0) | 40 (69.0) | <0.001 |
III-IV | 69 | 45 (65.2) | 24 (34.8) | |
Tumor depth | ||||
T1-T2 | 64 | 23 (35.9) | 41 (64.1) | 0.002 |
T3-T4 | 63 | 40 (63.5) | 23 (36.5) | |
Lymph node metastasis | ||||
N0-N1 | 65 | 22 (33.8) | 43 (66.2) | 0.001 |
N2-N3 | 62 | 41 (66.1) | 21 (33.9) | |
Distant metastasis | ||||
M0 | 119 | 57 (47.9) | 62 (52.1) | 0.138 |
M1 | 8 | 6 (75.0) | 2 (25.0) |